Dr. David Duffey is a seasoned healthcare executive and physician leader who has dedicated his career to transforming health systems through patient-centered innovation, strategic leadership, and compassionate care. With over three decades of experience guiding clinical and operational excellence, he has led large-scale initiatives that improve outcomes, reduce disparities, and build cultures of trust and accountability. Known for his thoughtful approach to leadership, Dr. Duffey blends deep industry knowledge with a commitment to mentoring and collaboration—making him a powerful force for sustainable change in healthcare and beyond.

Sejal Jonas, PharmD, RPh, is a visionary healthcare executive with over three decades of experience shaping payer strategy, formulary management, and market access for some of the nation’s leading pharmaceutical and healthcare organizations. Known for her deep clinical knowledge, strategic acumen, and commitment to improving health outcomes, Sejal brings a rare ability to bridge the gap between innovation and execution. Her work has empowered brands to thrive in complex regulatory and reimbursement environments, while her leadership continues to influence how healthcare systems deliver value to patients and providers alike.

Laura Freedy is a visionary healthcare executive with more than three decades of experience leading innovation at the intersection of clinical operations, regulatory compliance, and payer-provider collaboration. Known for her integrity, strategic foresight, and commitment to driving meaningful change, Laura has held senior leadership roles across major healthcare organizations, including UnitedHealth Group, Optum, and HTC Global Services. Her ability to align business objectives with clinical and technological solutions has consistently delivered improved health outcomes and operational performance. Passionate about service and mentorship, Laura is now focused on board service where she can share her expertise and guide organizations toward impactful, sustainable growth.

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

Dr. Andrew King is a distinguished orthopedic surgeon, medical educator, and innovator in pediatric scoliosis treatment, with over 40 years of experience in spinal deformity care, surgical advancements, and medical research. A recognized leader in his field, he has served as Chairman of Orthopedic Surgery at LSU Health Sciences Center and played a pivotal role in shaping pediatric orthopedic education and surgical techniques. His expertise extends beyond clinical practice, as he has consulted for leading medical device companies, contributed to groundbreaking research, and lectured globally on spinal deformities. As G. Dean MacEwen Professor Emeritus, Dr. King continues to bridge the gap between medical innovation and business strategy, seeking to contribute his deep industry knowledge and leadership to organizations dedicated to advancing healthcare and medical technology.

Vidura Stich is a transformational healthcare executive with deep expertise in digital product leadership, organizational design, and enterprise program management. Known for his strategic vision and people-first approach, he has successfully led large-scale transformations across CVS Health, Blue Shield of California, Kaiser Permanente, and Butterfly Network. With a proven ability to build high-performing teams, design scalable structures, and implement digital strategies that drive measurable results, Vidura excels in guiding organizations through complex change while improving service delivery, operational efficiency, and stakeholder engagement.

Jared Matthew Singleton is a results-oriented executive whose career is defined by strategic growth, operational excellence, and values-driven leadership. With over 14 years of experience spanning healthcare, environmental services, finance, and manufacturing, Jared brings a unique blend of business acumen, team leadership, and community commitment to every role he undertakes. Known for his ability to transform vision into action, he has led multimillion-dollar operations, negotiated complex partnerships, and consistently delivered top-line growth and profitability. Guided by the principles of servant leadership, consistency, impact, and drive, Jared is a sought-after voice in both corporate and nonprofit arenas, and a strong advocate for authentic leadership in today’s evolving business landscape.

I’m excited to share my professional executive biography, highlighting my journey in healthcare governance, business strategy, and patient advocacy. My passion lies in driving strategic growth, fostering leadership development, and improving patient care through governance excellence. As I continue serving on boards and expanding my impact, I welcome opportunities to collaborate with organizations seeking innovative leadership and transformative solutions.

Thrilled to share my professional biography, which captures the arc of my 30+ year journey across life sciences, innovation, strategy, and global health. I’ve had the honor of collaborating with visionary leaders and organizations to unlock transformative value at the intersection of science, business, and impact.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

After nearly four decades of leading strategic initiatives across healthcare, telecom, and government, I’m honored to share my professional executive biography. From building public benefit programs to mentoring leaders and advising on national policy, I remain grounded in service and focused on solving the right problems the right way. Here is my biography.

Jennifer T. Feldman, MBA, HTL (ASCP), QIHC, is a visionary healthcare business development leader with over 23 years of experience in oncology diagnostics, medical devices, and biotechnology. She has a proven track record of driving strategic partnerships, advancing innovative technologies, and optimizing commercial success in the healthcare industry. Jennifer’s expertise spans clinical pathology, research-use-only applications, and companion diagnostics, making her a key player in transforming patient care. With an MBA in International Business and certifications in histotechnology and immunohistochemistry, she seamlessly blends technical proficiency with business acumen. A sought-after speaker and industry expert, Jennifer is passionate about leveraging her knowledge and leadership to foster innovation, improve healthcare outcomes, and contribute to the future of medical advancements.

I am excited to share my executive biography, which reflects my journey in healthcare leadership, nursing education, and AI-driven innovation. Throughout my career, I have been committed to empowering nurses, improving patient care, and integrating technology into healthcare. My work spans teaching, consulting, leadership, and strategic planning, and I look forward to continuing to drive meaningful change in the industry.

I am excited to share my executive biography, highlighting my journey in oncology, clinical research, and medical affairs over the past 25 years. From my work as a medical science liaison to my leadership in pharmacy education and healthcare consulting, I have been committed to advancing patient care, scientific innovation, and medical education. If you're interested in learning more about my background, expertise, and contributions to pharmaceutical sciences and healthcare strategy.

Enterprise Architecture (EA) in healthcare has evolved from a rigid methodology into a dynamic strategic mindset, shaping the industry's ability to adapt to modern challenges. Initially focused on aligning IT infrastructure with business objectives, EA has transformed into a framework that drives operational efficiency, enhances patient engagement, and integrates emerging technologies like AI and cloud computing. By embracing strategy and rationalization, healthcare organizations can optimize resources, streamline workflows, and improve interoperability, ultimately delivering higher-quality, value-based care. As the industry continues to advance, EA’s role as a strategic enabler will remain crucial in shaping the future of healthcare.

As a healthcare entrepreneur, optometrist, and consultant, I have spent the past 24 years advancing patient care, pioneering dry eye treatment innovations, and helping optometric practices succeed in an evolving industry. My journey has been driven by a passion for education, mentorship, and business strategy, ensuring that practitioners can provide exceptional care while maximizing their practice’s potential. I am now looking to bring my expertise to board opportunities in healthcare, pharma, and optometry-related organizations.